Menopause Might Become Optional for Women
What: New tech and drugs like rapamycin aim to extend ovarian function.
Key Line: “You want to extend normal heart function… but slowing ovarian aging touches a very different note.”
Meta-analysis finds prenatal cannabis use raises risks of preterm and low birth weight.
Report finds mortality jumped in Texas post-ban; researchers call it a canary in the coal mine.
Study shows women over 70 who screened regularly were diagnosed earlier and had lower mortality.
Systemic hormones may worsen incontinence; local therapy helps, study says.
DOJ says states can’t overrule FDA—even as future restrictions loom.
Drew Altman breaks down the real-world consequences of Kennedy’s sweeping HHS overhaul.
A study finds women with incontinence are more likely to have heart disease risk factors.
NPR adds more detail to WHI’s shutdown and the loss of 1990s-era women’s health data.
An editorial calls for moving beyond reproductive-only focus in women’s health.
New Scientist highlights lack of support for bed rest during pregnancy and its risks.
WHI funding restored after backlash; $140 saved for every dollar spent, researchers say.
New GLP-1 pill for diabetes patients shows 7%+ weight loss, boosting Eli Lilly stock.
Luxury spa resort launches new “Inner Glow” retreat focused on hormone health and long-term wellness.
Even with dye bans, ultra-processed food remains the real issue, The Atlantic argues.
Over a dozen states are considering bills to expand menopause care and insurance coverage.
ADF targets birth control and IUD coverage in campaign to cut ties with ACOG.
Yale study shows women in Southern states barely gained life expectancy over 100 years.
Makary says he won’t act on mifepristone for now, but is “awaiting more data.”
Study finds no mass OBGYN flight from states with abortion bans—yet.
Interleukin-6 shows early promise in detecting life-threatening sepsis.